Recent Consensus Statements in Pediatric Endocrinology: A Selective Review

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 4, 2009, Pages 811-825

  Klein, Michelle ^a   Sathasivam, Anpalakan ^a   Novoa, Yeray ^a   Rapaport, Robert ^a  

^a MOUNT SINAI HOSPITAL   (United States)

Author keywords

Consensus statements; Diabetic ketoacidosis; Idiopathic short stature; Intersex disorders; Small for gestational age

Indexed keywords

ANABOLIC AGENT; AROMATASE INHIBITOR; ATYPICAL ANTIPSYCHOTIC AGENT; BICARBONATE; DIAZOXIDE; ESTROGEN; GESTAGEN; GLUCOCORTICOID; GONADORELIN DERIVATIVE; INSULIN; MANNITOL; OXANDROLONE; RECOMBINANT GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADULTHOOD; BRAIN EDEMA; CHILD; CHILD DEVELOPMENT; CHILD GROWTH; CHILD HEALTH CARE; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DIABETIC KETOACIDOSIS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EARLY DIAGNOSIS; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; FLUID THERAPY; HERMAPHRODITISM; HIGH RISK POPULATION; HUMAN; HYPOGONADISM; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LOW DRUG DOSE; MORBIDITY; PATIENT MONITORING; PHYSICAL EXAMINATION; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; PUBERTY; REVIEW; SEX DIFFERENTIATION DISORDER; SHORT STATURE; SMALL FOR DATE INFANT; SUPPORT GROUP; TREATMENT DURATION; UROLOGIC SURGERY;

ADOLESCENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CONSENSUS; CONTINUITY OF PATIENT CARE; DIABETIC KETOACIDOSIS; ENDOCRINOLOGY; GROWTH DISORDERS; HERMAPHRODITISM; HUMANS; INFANT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC;

EID: 70449864536     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.09.003     Document Type: Review

References (18)

1. Rycroft-Malone J. Formal consensus: the development of a national clinical guideline. Qual Health Care 10 (2001) 238-244
2. Grimshaw J.M., and Russel I.T. Achieving health gains through clinical guidelines: I. Developing scientifically valid guidelines. Qual Assur Health Care 2 (1993) 243-248
3. Dunger D.B., Sperling M.A., Acerini C.L., et al. European Society for Pediatric Endocrinology/Lawson Wilkins Pediatric Endocrine Society consensus statement on diabetic ketoacidosis in children and adolescents. Pediatrics 113 (2004) e133-e140
4. Wolfsdorf J., Glaser N., and Sperling M.A. Diabetic ketoacidosis in infants, children, and adolescents. A consensus statement from the American Diabetes Association. Diabetes Care 29 5 (2006) 1150-1159
5. Wolfsdorf J., Craig M.E., Daneman D., et al. ISPAD Clinical practice consensus guidelines 2006-2007. Diabetic ketoacidosis. Pediatr Diabetes 8 (2007) 28-43
6. Dunger D.B., Sperling M.A., Acerni C.L., et al. ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child 89 (2004) 188-194
7. Cohen P., Rogol A.D., Deal C.L., et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93 11 (2008) 4210-4217
8. Lee M. Idiopathic short stature. N Engl J Med 354 (2006) 2576-2582
9. Wit J., Rekers-Mombarg L., Cutler G., et al. Growth hormone treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146 (2004) 45-53
10. Quigley C., Gill A., Crowe B., et al. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 90 (2005) 5188-5196
11. Hero M., Norjavaara E., and Dunkel L. Inhibition of estrogen biosíntesis with a potent aromatase inhibitor increases predicted adult height in boys with idiopathic short stature: a randomized controlled trial. J Clin Endocrinol Metab 90 (2005) 6396-6402
12. Hero M., Wickman S., and Dunkel L. Treatment with the aromastase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty. Clin Endocrinol 64 (2006) 510-513
13. Clayton P.E., Cianfarani S., Czernichow P., et al. Consensus statement: management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 92 3 (2007) 804-810
14. Rapaport R., Saenger P., Wajnrajch M.P., et al. Predictors of first-year growth response to a fixed-dose of growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States. J Pediatr Endocrinol Metab 21 (2008) 411-422
15. Lee P.A., Houk C.P., Ahmed S.F., et al. Consensus statement on Management of Intersex Disorders. International Consensus Conference on Intersex. Pediatrics 118 (2006) e488-e500
16. Hughes I. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 22 1 (2008) 119-134
17. Rapaport R. Disorders of the gonads. In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson textbook of pediatrics. 17th edition (2004), Saunders, Philadelphia 1921-1946
18. Klein G., and Rapaport R. Early diagnosis and management of atypical-appearing genitalia. In: Altchek A., and Deligdisch L. (Eds). Pediatric, adolescent and young adult gynecology (2009), Wiley-Blackwell, West Sussex, UK 14-24